Citadel Advisors’s BlackRock Health Sciences Trust BME Stock Holding History

Citadel Advisors’s Portfolio BME Stock Details BME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$355K	Buy	+8,262	New	+$328K	﹤0.01%	10725

Other funds holding BME

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

1CP

1607 Capital Partners Richmond, Virginia $1.15B AUM 12.28% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

NRW

Nova R Wealth Overland Park, Kansas $343M AUM 17.7% 1-Year Est. Return

Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Citadel Advisors's BME Position: Q2 2026 in Review

Citadel Advisors opened a new position in BlackRock Health Sciences Trust (BME) in Q2 2026: 8,262 shares worth $355K. The stake represents ﹤0.01% of the portfolio and ranks #10725 among its holdings.

78 funds tracked by Wall St. Rank hold BME as of Q2 2026.

Citadel Advisors held 8,262 shares of BlackRock Health Sciences Trust worth $355K as of Q2 2026.
BlackRock Health Sciences Trust was a new Citadel Advisors position in Q2 2026.
BlackRock Health Sciences Trust made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #10725 holding.
78 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.